These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 23234208)

  • 1. [Drug-induced proteinuria].
    Ogawa M
    Nihon Jinzo Gakkai Shi; 2012; 54(7):981-4. PubMed ID: 23234208
    [No Abstract]   [Full Text] [Related]  

  • 2. Statin induced proteinuria: renal injury or renoprotection?
    Agarwal R
    J Am Soc Nephrol; 2004 Sep; 15(9):2502-3. PubMed ID: 15340001
    [No Abstract]   [Full Text] [Related]  

  • 3. [Proteinuria and cadmium nephropathy].
    Pernis B; Governa M; Castano P
    Minerva Nefrol; 1968; 15(3):129-41. PubMed ID: 5706233
    [No Abstract]   [Full Text] [Related]  

  • 4. The relationship between D-penicillamine--induced proteinuria and prior gold nephropathy.
    Billingsley LM; Stevens MB
    Johns Hopkins Med J; 1981 Feb; 148(2):64-7. PubMed ID: 7206401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-induced nephrotoxicity.
    Krumlovsky FA
    Arch Dermatol; 1983 Aug; 119(8):681-2. PubMed ID: 6870322
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug-induced glomerulopathy: a selective review.
    Dumler F
    Henry Ford Hosp Med J; 1983; 31(2):110-4. PubMed ID: 6414992
    [No Abstract]   [Full Text] [Related]  

  • 7. Penicillamine nephropathy.
    Br Med J (Clin Res Ed); 1981 Mar; 282(6266):761-2. PubMed ID: 6783160
    [No Abstract]   [Full Text] [Related]  

  • 8. Tamm-Horsfall mucoprotein. 3. Potassium dichromate-induced renal tubular damage.
    Schwartz RH; Lewis RA; Schenk EA
    Lab Invest; 1972 Aug; 27(2):214-7. PubMed ID: 4560092
    [No Abstract]   [Full Text] [Related]  

  • 9. [Nephrotic syndrome secondary to d-penicillamine in a patient with Wilson's disease].
    Castellví Suaña JM; Xiol Quingles X; Castellote Alonso J; Guardiola Capón J
    Rev Clin Esp; 1993 Oct; 193(6):343-4. PubMed ID: 8259463
    [No Abstract]   [Full Text] [Related]  

  • 10. ["Itai-itai" disease and proteinuria caused by cadmium poisoning].
    Fukuyama Y
    Igaku To Seibutsugaku; 1972 Jan; 84(1):41-6. PubMed ID: 5064398
    [No Abstract]   [Full Text] [Related]  

  • 11. The mTOR inhibitor everolimus induces proteinuria and renal deterioration in the remnant kidney model in the rat.
    Vogelbacher R; Wittmann S; Braun A; Daniel C; Hugo C
    Transplantation; 2007 Dec; 84(11):1492-9. PubMed ID: 18091526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Renal complications od chrysothiotherapy in progressive polyarthritis].
    Hándlová D
    Vnitr Lek; 1968 Feb; 14(2):115-8. PubMed ID: 5637529
    [No Abstract]   [Full Text] [Related]  

  • 13. [Renal damage in experimental cadmium poisoning in the mouse].
    Kubota K; Matsue R; Fukuyama Y; Ishimoto M; Takayanagi N
    Igaku To Seibutsugaku; 1970 Jun; 80(6):315-20. PubMed ID: 5465521
    [No Abstract]   [Full Text] [Related]  

  • 14. Aminonucleoside-induced renal disease in newborn rats.
    Vilska J
    Ann Med Exp Biol Fenn; 1969; 47(2):73-91. PubMed ID: 5391186
    [No Abstract]   [Full Text] [Related]  

  • 15. The natural course of gold nephropathy.
    Hunter JA; Capell HA
    Br Med J (Clin Res Ed); 1987 Nov; 295(6609):1350. PubMed ID: 3121009
    [No Abstract]   [Full Text] [Related]  

  • 16. Proteinuria: changes and mechanisms in toxic nephropathies.
    Bernard A; Lauwerys RR
    Crit Rev Toxicol; 1991; 21(5):373-405. PubMed ID: 1741950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Asymptomatic urinary anomalies, hematuria and proteinuria, in patients with inflammatory bowel disease. Preliminary study.
    Velciov S; Gluhovschi G; Sporea I; Trandafirescu V; Petrica L; Bozdog G; Gluhovschi C; Bob F; Gădălean F; Buzaş R; Bobu M; Voicu L
    Rom J Intern Med; 2011; 49(2):113-20. PubMed ID: 22303602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Early urinary markers of aminoglycoside nephrotoxicity (author's transl)].
    Nicot G; Charmes JP; Valette JP; Merle L; Dany F; Brosset P; Lachatre G
    Therapie; 1980; 35(3):369-74. PubMed ID: 7423429
    [No Abstract]   [Full Text] [Related]  

  • 19. VEGF signalling inhibition-induced proteinuria: Mechanisms, significance and management.
    Izzedine H; Massard C; Spano JP; Goldwasser F; Khayat D; Soria JC
    Eur J Cancer; 2010 Jan; 46(2):439-48. PubMed ID: 20006922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An assessment of statin safety by nephrologists.
    Kasiske BL; Wanner C; O'Neill WC;
    Am J Cardiol; 2006 Apr; 97(8A):82C-85C. PubMed ID: 16581334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.